Cisapride market to be more competitive by Hanmi's new entry.

Hanmi introduced Cisaple tablet (Cisapride 5mg), a GI motility regulator to compete with Janssen's Prepulcid and other's Cisapride generic markets.

Cisapride generics were introduced recently by Daewoong and Kyungdong, and now Hanmi also released Cisapride preparations to the market, claiming that its patent was filed in Jan. last year and the therapeutic efficacy was confirmed by the clini...